Your browser doesn't support javascript.
loading
Dynamic of anti-spike receptor binding domain (RBD) levels and short-term adverse events following a heterologous booster dose of BNT162b2 after two doses of CoronaVac in Thai health care workers.
Kitro, Amonrphat; Sirikul, Wachiranun; Thongkum, Weeraya; Soponpong, Suthinee; Yasamut, Umpa; Kiratipaisarl, Wuttipat; Kosai, Apiradee; Kasinrerk, Watchara; Tayapiwatana, Chatchai; Srithanaviboonchai, Kriengkrai.
Afiliación
  • Kitro A; Department of Community Medicine, Faculty of Medicine, Chiang Mai University, Thailand.
  • Sirikul W; Department of Community Medicine, Faculty of Medicine, Chiang Mai University, Thailand.
  • Thongkum W; Center of Biomolecular Therapy and Diagnostic, Faculty of Associated Medical Sciences, Chiang Mai University, Thailand; Center of Innovative Immunodiagnostic Development, Faculty of Associated Medical Sciences, Chiang Mai University, Thailand.
  • Soponpong S; Center of Biomolecular Therapy and Diagnostic, Faculty of Associated Medical Sciences, Chiang Mai University, Thailand; Center of Innovative Immunodiagnostic Development, Faculty of Associated Medical Sciences, Chiang Mai University, Thailand.
  • Yasamut U; Center of Biomolecular Therapy and Diagnostic, Faculty of Associated Medical Sciences, Chiang Mai University, Thailand; Center of Innovative Immunodiagnostic Development, Faculty of Associated Medical Sciences, Chiang Mai University, Thailand; Division of Clinical Immunology, Department of Medical T
  • Kiratipaisarl W; Faculty of Medicine, Chiang Mai University, Thailand.
  • Kosai A; Faculty of Medicine, Chiang Mai University, Thailand.
  • Kasinrerk W; Center of Biomolecular Therapy and Diagnostic, Faculty of Associated Medical Sciences, Chiang Mai University, Thailand; Center of Innovative Immunodiagnostic Development, Faculty of Associated Medical Sciences, Chiang Mai University, Thailand.
  • Tayapiwatana C; Center of Biomolecular Therapy and Diagnostic, Faculty of Associated Medical Sciences, Chiang Mai University, Thailand; Center of Innovative Immunodiagnostic Development, Faculty of Associated Medical Sciences, Chiang Mai University, Thailand; Division of Clinical Immunology, Department of Medical T
  • Srithanaviboonchai K; Department of Community Medicine, Faculty of Medicine, Chiang Mai University, Thailand; Research Institute for Health Sciences, Chiang Mai University, Thailand. Electronic address: kriengkrai.s@cmu.ac.th.
Vaccine ; 40(21): 2915-2924, 2022 05 09.
Article en En | MEDLINE | ID: mdl-35430106
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Adult / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article País de afiliación: Tailandia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Adult / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article País de afiliación: Tailandia